Related Experiment Video
Updated: Jul 15, 2025
08:02
In Vivo Augmentation of Gut-Homing Regulatory T Cell Induction
Published on: January 22, 2020
5.5K
Vaccination therapy for inflammatory bowel disease.
Human Vaccines & Immunotherapeutics
|September 29, 2023
Summary
Therapeutic vaccines offer a promising alternative for inflammatory bowel disease (IBD) management, potentially improving efficacy and reducing side effects compared to current treatments.
Area of Science:
- Immunology and Gastroenterology
- Novel therapeutic strategies for autoimmune diseases
Background:
- Current inflammatory bowel disease (IBD) treatments like Ustekinumab, Infliximab, and Vedolizumab show limitations in response rates and adverse effects.
- The need for safer and more effective IBD management strategies is critical.
Purpose of the Study:
- To review the existing literature on therapeutic vaccines for IBD.
- To provide researchers with a comprehensive understanding of vaccine applications and prospects in IBD.
- To stimulate innovative vaccine development for IBD treatment.
Main Methods:
- Critical examination of current scientific literature on therapeutic vaccines for IBD.
- Analysis of immunological research advancements relevant to vaccine development.
- Evaluation of vaccine efficacy, safety, and potential healthcare burden reduction.
Main Results:
- Therapeutic vaccines aim to harness the immune system to generate specific antibodies for IBD treatment.
- Vaccines present a potentially more favorable approach due to improved efficacy and safety profiles.
- Potential to mitigate the financial and healthcare burden associated with IBD management.
Conclusions:
- Therapeutic vaccines represent a promising frontier in IBD management.
- Further research and development are needed to optimize vaccine strategies for IBD.
- Vaccine-based therapies could offer a sustainable and effective long-term solution for IBD patients.
Keywords:
Inflammatory bowel diseaseParasite vaccineangiogenesisintestinal immunityintestinal microbiotavaccination therapyMore Related Videos
Related Concept Videos
01:29Inflammatory Bowel Disease IV: Pharmacological Management
145
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
145
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
186
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
186
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
164
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
164
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
348
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
348
01:29Drugs for Treatment of Ulcerative Colitis in IBD
164
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
164